Not currently recruiting at UCSF
Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies
Summary
- Eligibility
- for people ages 18-130 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Pamela Munster
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Pamela Munster
Professor, Medicine, School of Medicine. Authored (or co-authored) 139 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- AstraZeneca
- Links
- BreastCancerStudyLocator.com
- ID
- NCT04644068
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 715 study participants
- Last Updated